Microcirculation in Venoarterial Extracorporeal Membrane Oxygenation Life Support

April 19, 2018 updated by: National Taiwan University Hospital

Investigation of Microcirculation in Patients With Venoarterial Extracorporeal Membrane Oxygenation Life Support

Extra-corporeal membrane oxygenation (ECMO) life support system can provide both cardiac and respiratory support to patients with heart and respiratory failure. It can save time for these organs to recovery or for these patients to receive further management. However, many patients will die in spite of ECMO support. One of the key factor is whether the blood flow provided by the ECMO can meet the requirement of organ perfusion. The adequacy of macrocirculation may be determined by arterial pressure and minute blood flow of ECMO. However, the adequacy of microcirculation remains as a major unresolved clinical problem. This is a prospective observational clinical trial. The sublingual microcirculation will be examined with the incident dark field video microscope within 6 hours after venoarterial ECMO placement, and then at 24 h, 48 h, 72 h, and 96 h. The severity of multiple organ injury and clinical data will be recorded as well. The major parameters of microcirculation include total small vessel density, perfused small vessel density, and microvascular flow index. The sublingual microcirculation will also be examined before weaning off ECMO, within 6 hours after ECMO removal, and then at 24 h, 48 h, and 72 h. Serum level of endothelial cell specific molecule-1 at specific time points will be examined. The data of 14-day mortality, 28-day mortality, duration of ECMO support, and intensive care unit stay will be recorded. This study aims primarily to investigate the relationship between microcirculation and prognosis of these patients. This study will also investigate the relationship among serum level of endothelial cell specific molecule-1, microcirculation, and prognosis of these patients. Wish the results of this study can be applied in further research to help to improve the quality of ECMO care.

Study Overview

Study Type

Observational

Enrollment (Actual)

48

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan, 100
        • National Taiwan University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 79 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support

Description

Inclusion Criteria:

  • Patients who require venoarterial extra-corporeal membrane oxygenation (ECMO) life support

Exclusion Criteria:

  • who can not take an examination of sublingual microcirculation within 6 hours after placement of venoarterial ECMO support
  • Non-native speakers

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
28-day Survival
survive for at least 28 days after placement of extra-corporeal membrane oxygenation life support
venoarterial extra-corporeal membrane oxygenation life support
28-day Nonsurvival
not survive for 28 days after placement of extra-corporeal membrane oxygenation life support
venoarterial extra-corporeal membrane oxygenation life support

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfused small vessel density
Time Frame: At enrollment (within 12 hour after placement of extra-corporeal membrane oxygenation life support)
Perfused small vessel density measured by incident dark field video microscope
At enrollment (within 12 hour after placement of extra-corporeal membrane oxygenation life support)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total small vessel density
Time Frame: At Enrollment
Total small vessel density measured by incident dark field video microscope
At Enrollment
Endocan level
Time Frame: At enrollment
At enrollment
Microvascular flow index
Time Frame: At enrollment
Microvascular flow index measured by incident dark field video microscope
At enrollment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2015

Primary Completion (Actual)

August 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

March 15, 2015

First Submitted That Met QC Criteria

March 15, 2015

First Posted (Estimate)

March 19, 2015

Study Record Updates

Last Update Posted (Actual)

April 23, 2018

Last Update Submitted That Met QC Criteria

April 19, 2018

Last Verified

December 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • 201412045RINA

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Heart Failure

Clinical Trials on Extra-corporeal membrane oxygenation life support

Subscribe